U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof

Patent 5574068 Issued on November 12, 1996. Estimated Expiration Date: Icon_subject November 14, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Method for treatment of angina and myocardial infarctions with omental lipids
Patent #: 4778787
Issued on: 10/18/1988
Inventor: Catsimpoolas ,   et al.

Nitrosothiols as hypotensive agents
Patent #: 4900719
Issued on: 02/13/1990
Inventor: Means, et al.

S-nitrosocaptopril compounds and the use thereof
Patent #: 5002964
Issued on: 03/26/1991
Inventor: Loscalzo

S-nitroso derivatives of ACE inhibitors and the use thereof
Patent #: 5025001
Issued on: 06/18/1991
Inventor: Loscalzo, et al.

Nitrosothiol derivatives and their use
Patent #: 5116861
Issued on: 05/26/1992
Inventor: Goto, et al.

S-nitroso derivatives of ACE inhibitors and the use thereof
Patent #: 5187183
Issued on: 02/16/1993
Inventor: Loscalzo, et al.

S-nitroso derivatives of ace inhibitors and the use thereof
Patent #: 5356890
Issued on: 10/18/1994
Inventor: Loscalzo, et al.

S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
Patent #: 5380758
Issued on: 01/10/1995
Inventor: Stamler, et al.

Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders Patent #: 5405919
Issued on: 04/11/1995
Inventor: Keefer, et al.

Inventors

Assignee

Application

No. 338893 filed on 11/14/1994

US Classes:

514/562Sulfur nonionically bonded

Examiners

Primary: Lilling, Herbert J.

Attorney, Agent or Firm

Foreign Patent References

  • 0412699 EP. 02/13/1991
  • WO92/10228 WO. 06/13/1992

International Class

A61K 031/195

Abstract

S-nitrosothiols exert a potent relaxant effect, mediated both by guanylate cyclase, and a cGMP-independent mechanism, upon non-vascular smooth muscle. Such types of smooth muscle include airway, gastrointestinal, bladder, uterine and corpus cavernosal. Thus, S-nitrosothiols may be used for the treatment or prevention of disorders associated with relation of smooth muscle, such as airway obstruction, and other respiratory disorders, bladder dysfunction, premature labor and impotence. Additionally, S-nitrosothiols may be used to alleviate smooth muscle contraction and spasm, and thus facilitate procedures involving diagnostic instrumentation, such as endoscopy, bronchoscopy, laparoscopy and cystoscopy. S-nitrosothiols also increase the binding affinity between hemoglobin and oxygen, and therefore, may be used to improve hemoglobin-oxygen binding, and oxygen transport to bodily tissues.

Other References

  • Furchgott, R., Endothelium-Dependent Relaxation in Systemic Arteries in Relaxing and Contracting Factors, Human Press, New Jersey, pp. 1-26 (1988)
  • Hata, R. et al. Dissociation of cyclic GMP level and nitric oxide-induced inhibitory responses in rat colon, Japanese Journal of Pharmacology, 58 Suppl. 2:387P (1992). (Abstract only)
  • Robinson, Differences in response to dilator agents in blood vessels of different types: physiological bases for selectivity, Journal of Hypertension, 7:S147-S151 (1989)
  • Nakatsu K. et al., Role of cGMP in relaxation of vascular and other smooth muscle [Review], Canadian Journal of Physiology & Pharmacology, 67(4):251-62 (Apr. 1989). (Abstract only)
  • Gatson et al., Endogenous nitrogen oxides and broncho-dilator S-nitrosothiols in human airways, Proc. Natl. Acad. Sci. USA, 90:10957-10961 (Dec. 1993)
  • Aldred et al., Kinetics and Mechanism of the Nitrosation of Alcohols, Carbohydrates, and a Thiol, J.C.S. Perkin Trans., II:777-(1982)
  • Buga et al., Endothelium-derived nitric oxide relaxes nonvascular smooth muscle, Eur. J. Pharm., 161:61-72 (1989)
  • Byler et al., Spectroscopic Estimation of the Extent of S-Nitrosothiol Formation by Nitrite Action on Sulfhydryl Groups., J. Agric Food Chem., 31:523-527 91983)
  • Cocks et al., Comparison of relaxation responses of vascular and non-vascular smooth muscle to endothelium-derived relaxing factor (EDRP) . . . , Naunyn-Schmiedeberg's Arch. Pharmacol., 341:364-372 (1990)
  • Cooke et al., Flow stimualtes endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol, Am. J. Physiol, 259(3):H804-H812 (1990)
  • Dusting et al., Endothelium-Derived Relaxing Factor Released From Cultured Cells: Differentation From Nitric Oxide, Clin. Exper. Pharm. Physiol., 15:83-92 (1988)
  • Fung et al., Mechanism for the Pharmacologic Interaction of Organic Nitrates with Thiols. Existence of and Extracellular Pathway for the Reversal of . . . , J. Pharm. Exper. Ther., 245(2):524-530 (1988)
  • Gaston et al., S-Nitrosothiols Are Stable Forms of NO That Relax Human Airways: Implications for Inflammatory and Immune Disease States, Abstract presented at Nitric oxide Meeting Sep. 15, 1992
  • Gruetter et al., Comparison of Relaxation Induced by Glyceryl Trinitrate, Isosorbide Dinitrate, and Sodium Nitroprusside in Bovine Airways, Am. Rev. Respir. Dis., 139:1192-1197 (1989)
  • Gryglewski et al., Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor, Nature, 320:454-456 (1986)
  • Heaton et al., Topical Glyceryltrinitrate Causes Measurable Penile Arterial Dilation in Impotent Men, J. Urology, 143:729-731 (1990)
  • Henry et al., S-nitrosothiols as vasodialators: implications regarding tolerance to nitric oxide-containing vasodialators, Br. J. Pharmacol., 98:757-766 (1989)
  • Holmquist et al., L-NG -nitro arginine inhibits non-cholinergic relaxation og human isolated corpus cavernosum, Acta Physiol. Scand., 141:441-442 (1991)
  • Ignarro et al., Nitric Oxide and Cyclic GMP Formation Upon Electrical Field Stimulation Cause Relaxation of Corpus Cavernosum Smooth Muscle, Biochem. Biophys. Res. Comm., 170(2):843-850 (1990)
  • Ignarro et al., Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide, Proc. Natl. Acad. Sci. USA, 84:9265-9269 (1987)
  • Ignarro et al., Mechanism of Vascular Smooth Muscle Relaxation of Organic Nitrites, Nitrites Nitroprusside and Nitric Oxide: Evidence for the . . . , J. Pharm. Exp. Ther., 218(3):739-749 (1990)
  • Ignarro et al., Haem-Dependent Activation of Guanylate Cyclase and Cyclic GMP Formation by Endogenous Nitric Oxide: A Unique Transduction . . . , Pharmacology and Toxicology, 67:1-7 (1990)
  • Ignarro et al., Biological Actions and Propertiers of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein, Circulation Research, 65(1):1-21 (1989)
  • Jeong et al., Effects of Glyceryl Trinitrate on Guinea-Pig Tracheal Smooth Muscle, Am. Rev. Dis., 117:133 (1978)
  • Katsuki et al., Effects of Sodium Nitroprusside, Nitroglycerin, and Sodium Azide on Levels of Cyclic Nucleotides and Mechanical Activity of Various Tissues, J. Cyc. Nuc. Res., 3:239-247 (1977)
  • Kishen et al., Some actions of sodium nitroprusside and glyceryl trinitrate on guinea-pig isolated trachealios muscle, J. Pharm. Pharmacol. 37:502-504 (1984)
  • Kowaluk et al., Spontaneous Liberation of Nitric Oxide Cannot Account for in Vitro Vascular Relaxtion by S-Nitrosothiols, J. Pharm. Exp. Ther., 255(3):1256-1264 (1990)
  • Li et al., Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus, Eur. J. Pharm., 191:303-309 (1980)
  • Long et al., Anion exchange resins discriminate between nitric oxide and EDRF, Eur. J. Pharm., 142:317-318 (1987)
  • Loscalzo et al., S-Nitrosocaptopril. I. Molecular Characterization and Effects on the Vasculature and on Plants, J. Pharm. Exp. Ther., 249(3):726-729 (1989)
  • Marletta, J. A., Nitric oxide: biosynthesis and biological significance, TIBS, 14:488-492 (1989)
  • Morales et al., The medical treatment of importence: an update, World J. Urol, 8:80-83 (1990)
  • Myers et al., Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide, Nature, 345:151-163 (1990)
  • Oae et al., Organic thionitrites and Related Substances. A review, Org. Prep. Proc. Int., 15(3):165-198 (1983)
  • Palmet et al., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327:524-526 (1987)
  • Shikano et al., Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscle, Br. J. Pharmc., 92:483-485 (1987)
  • Shikano et al., Endothelium-Derived relaxing factor is a Selective relaxant of Vascular Smooth Muscle, J. Pharm. Exp. Ther., 243 (1):55-60 (1987)
  • Stamler et al., S-Nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds, Proc. Natl. Acad. Sci. USA, 89:444-448 (1992)
  • Staritz, J. Pharmacology of the Sphincter of oddi, Endoscopy, 20:171-174 (1988)
  • Suzuki et al., The Relationship Between Tissue Levels of Cyclic GMP and Tracheal Smooth Muscle Relaxation in the Guinea-Pig, Clin. Exp. Pharm. Physiol. 13:39-46 (1986)
  • Vanhoutte, P. M., Epithelium-derived Relaxing Factor(s) and Bronchial Reactivity, Am. Rev. Respir, Dis., 138:s24-s30 (1988)
  • Vickers et al., Corpora Cavernosa Ultrastructure in Vascular Erectile Dysfunction, Journal of Urology, 143:1131-1134 (1990)
  • Gaston et al., Relaxation of Human Airways in vitro by S-nitrosothiols, Rev. Resp. Dis., 145 (4pt.2):A383 (1991
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?